16 stocks GMO is backing right now

Let's face it - global investing is a tough nut to crack right now. Between the war in Ukraine steering the Eurozone straight into a recession to the US Federal Reserve's "whatever it takes" policy to fight inflation, to the unfolding property crisis in China, making solid returns in faraway lands is just that - far away.

So how does a global fund manager tackle these trying times? For Kim Mayer at GMO, his process is simple: create a universe of quality investments and own them at attractive valuations. While that philosophy is consistent, what may be surprising is that the GMO Focused Equity fund is weighted heavily toward the US. In fact, 75% of its portfolio is US-domiciled.

In this latest edition of Expert Insights, Kim discusses the landscape for global equities right now. Plus, he also shares which sectors are best positioned for the rest of 2022, what themes the GMO team wants to harness, as well as 16 of their top stock picks (and 1 on his watchlist).

Note: This interview was recorded on 16th August 2022.